Skip to main content
logo
Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
52.60
-0.20 (-0.38%)
Mar 12, 2026, 5:30 PM CET

Basilea Pharmaceutica AG Revenue

In the year 2025, Basilea Pharmaceutica AG had annual revenue of 232.38M CHF with 11.43% growth. Basilea Pharmaceutica AG had revenue of 128.42M in the half year ending December 31, 2025, with 76.57% growth.

Revenue
232.38M
Revenue Growth
+11.43%
P/S Ratio
2.79
Revenue / Employee
1.23M
Employees
189
Market Cap
649.00M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025232.38M23.84M11.43%
Dec 31, 2024208.54M50.91M32.30%
Dec 31, 2023157.63M9.87M6.68%
Dec 31, 2022147.77M-357.00K-0.24%
Dec 31, 2021148.12M20.49M16.06%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Idorsia220.58M
Newron Pharmaceuticals55.93M
Santhera Pharmaceuticals Holding AG49.02M
BioVersys AG1.31M
Xlife Sciences AG839.38K
Molecular Partners AG681.00K
Addex Therapeutics158.54K
Revenue Rankings

Basilea Pharmaceutica AG News

More News